In a groundbreaking stride toward understanding and eventually curing congenital deafness, researchers have successfully engineered genetically modified marmoset monkeys with a targeted disruption of the OTOF gene, a critical player in auditory signal transmission. This pioneering work, conducted by an interdisciplinary team from the German Primate Center – Leibniz Institute for Primate Research, the University Medical Center Göttingen, and the Max Planck Institute for Multidisciplinary Sciences, marks the first time a primate model has been created that authentically mirrors human OTOF-related deafness. The creatures, healthy and normally developing yet deaf from birth, offer an unprecedented window into the inner workings of hearing loss at a molecular and physiological level.
Hearing impairment ranks among the most common congenital sensory deficits worldwide, often rooted in genetic anomalies. Among these, mutations in the OTOF gene stand out prominently. The OTOF gene encodes the otoferlin protein, indispensable for synaptic transmission from inner ear hair cells to the auditory nerve. Without this molecular intermediary, sound stimuli fail to convert into electrical impulses perceivable by the brain, rendering the individual effectively deaf despite the structural integrity of their inner ear. Prior models, predominantly murine, have offered partial insight but fall short of replicating the intricate complexity of primate auditory physiology.
Employing the cutting-edge CRISPR/Cas9 genome-editing technology, the researchers introduced precise mutations into the fertilized eggs of marmoset monkeys to disable the OTOF gene. The ensuing embryos were implanted into a surrogate, resulting in offspring that developed impeccable health profiles but exhibited profound deafness from birth. Electrophysiological assessments, analogous to EEGs, confirmed the total absence of auditory evoked potentials. Further immunohistochemical analyses affirmed the lack of otoferlin protein in the inner hair cells, conclusively verifying the gene knockout and its functional consequences.
This breakthrough transcends mere model creation: it offers a vital tool for probing the pathophysiology of auditory synaptopathy in a system more analogous to humans than rodents. The marmoset’s auditory system shares key anatomical and electrophysiological traits with humans, including cochlear structure, frequency range, and neural circuitry, making it an invaluable asset for translational auditory research. These attributes facilitate the development, optimization, and long-term safety evaluation of innovative therapeutic strategies—particularly gene therapy and optogenetic cochlear implants—aimed at restoring hearing.
The development process for genetically modified primates presents formidable scientific and technical challenges. The collaboration among specialists in reproductive biology, genome editing, neuroscience, and veterinary medicine was essential to surmount these hurdles. Precise gene editing without mosaicism—where different cells contain different genetic edits—was critical to ensure consistency of phenotype and relevance to human conditions. The success achieved in this project demonstrates the potential for similarly sophisticated modifications to create additional primate models for diverse human diseases.
A significant implication of this endeavor lies in its translational potential. By faithfully replicating the human genetic and physiological context of OTOF-related deafness, these marmoset models provide the necessary preclinical platform to evaluate novel interventions with a high degree of predictive validity. The ability to monitor gene therapy vectors, assess functional recovery, and observe long-term outcomes in a primate brain sets a new standard in auditory research and therapeutic development.
The research was underpinned by generous funds from the Leibniz Cooperative Excellence Program, the DFG Cluster of Excellence MBExC, the DFG Collaborative Research Center 1690, and the Else Kröner Fresenius Center for Optogenetic Therapies. This financial and institutional support facilitated cutting-edge experimental designs, ensuring rigorous data collection and analysis.
Perhaps equally transformative is the ethical and operational precedent set by this study. The precision and care taken in creating non-mosaic gene disruptions and ensuring animal welfare demonstrate that complex genetic modifications can be responsibly undertaken in primates. This paves the way for a new era of biomedical research where primate models contribute decisively to understanding human diseases, particularly those inadequately modeled in rodents.
This OTOF gene knockout marmoset model also sheds light on the broader concept of auditory synaptopathies—conditions where synaptic transmission defects cause sensory deficits despite intact sensory cells. By differentiating between hair cell damage and synaptic malfunction, researchers can now dissect mechanisms that were previously inseparable in patient studies or simpler animal models.
Looking forward, this model not only accelerates auditory research but also underscores the potential for personalized medicine. Through iterative genetic and therapeutic studies, it becomes conceivable to tailor treatments based on individual genetic backgrounds, ultimately providing bespoke solutions for patients with genetically-mediated hearing loss.
In conclusion, the generation of an OTOF gene-disrupted marmoset primate model represents a paradigm shift in hearing loss research. By bridging the gap between rodent studies and clinical application, it promises to spearhead the next generation of targeted, safe, and effective treatments for millions affected by congenital deafness, illuminating pathways toward restoring one of humanity’s most vital senses.
Subject of Research: Animals
Article Title: Generation of marmoset monkeys with a non-mosaic disruption of the OTOF gene as a model of human deafness
News Publication Date: 28-Mar-2026
Web References:
http://dx.doi.org/10.1038/s41467-026-71047-1
Image Credits: Katharina Diederich / German Primate Center
Keywords: OTOF gene, otoferlin, congenital deafness, genetically modified marmosets, CRISPR/Cas9, auditory neuroscience, gene therapy, synaptopathy, cochlear implants, translational research, primate model, hearing loss
